Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression

Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal carcinoma (IDC), whereby if left untreated, approximately 12% of patients develop invasive disease. The current standard of care is surgical removal of the lesion, to prevent potential progression, and radiotherapy to red...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Gemma M., Dinh, Phuong, Pathmanathan, Nirmala, Graham, J. Dinny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135892/
https://www.ncbi.nlm.nih.gov/pubmed/35567670
http://dx.doi.org/10.1007/s10911-022-09517-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135892/
https://www.ncbi.nlm.nih.gov/pubmed/35567670
http://dx.doi.org/10.1007/s10911-022-09517-7

Ejemplares similares